This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2008 May:19 Suppl 2:ii83-5.

doi: 10.1093/annonc/mdn099.

Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up

R Stupp¹, F Roila; ESMO Guidelines Working Group

Affiliations

PMID: 18456781
DOI: 10.1093/annonc/mdn099

Free article

Practice Guideline

Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up

R Stupp et al. Ann Oncol. 2008 May.

Free article

. 2008 May:19 Suppl 2:ii83-5.

doi: 10.1093/annonc/mdn099.

Authors

R Stupp¹, F Roila; ESMO Guidelines Working Group

Affiliation

¹ Multidisciplinary Oncology Center, University of Lausanne Hospital, Lausanne, Switzerland.

PMID: 18456781
DOI: 10.1093/annonc/mdn099

No abstract available

PubMed Disclaimer

Similar articles

Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
ESMO Guidelines Working Group; Stupp R. ESMO Guidelines Working Group, et al. Ann Oncol. 2007 Apr;18 Suppl 2:ii69-70. doi: 10.1093/annonc/mdm044. Ann Oncol. 2007. PMID: 17491055 No abstract available.
Head's up on the treatment of malignant glioma patients.
Armstrong TS. Armstrong TS. Oncol Nurs Forum. 2009 Sep;36(5):E232-40. doi: 10.1188/09.ONF.E232-E240. Oncol Nurs Forum. 2009. PMID: 19726382 Review. No abstract available.
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Stupp R, Tonn JC, Brada M, Pentheroudakis G; ESMO Guidelines Working Group. Stupp R, et al. Ann Oncol. 2010 May;21 Suppl 5:v190-3. doi: 10.1093/annonc/mdq187. Ann Oncol. 2010. PMID: 20555079 No abstract available.
Long-term outcome of low-grade oligodendroglioma and mixed glioma.
Olson JD, Riedel E, DeAngelis LM. Olson JD, et al. Neurology. 2000 Apr 11;54(7):1442-8. doi: 10.1212/wnl.54.7.1442. Neurology. 2000. PMID: 10751254
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Stupp R, Roila F; ESMO Guidelines Working Group. Stupp R, et al. Ann Oncol. 2009 May;20 Suppl 4:126-8. doi: 10.1093/annonc/mdp151. Ann Oncol. 2009. PMID: 19454432 Review. No abstract available.

See all similar articles

Cited by

GGNBP2 Suppresses the Proliferation, Invasion, and Migration of Human Glioma Cells.
Zhan A, Lei B, Wu H, Wen Y, Zheng L, Wang S, Wan X, Wei Z. Zhan A, et al. Oncol Res. 2017 May 24;25(5):831-842. doi: 10.3727/096504016X14816726393937. Epub 2016 Dec 15. Oncol Res. 2017. PMID: 28244851 Free PMC article.
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.
Lieberman FS, Wang M, Robins HI, Tsien CI, Curran WJ Jr, Werner-Wasik M, Smith RP, Schultz C, Hartford AC, Zhang P, Mehta MP. Lieberman FS, et al. Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):878-886. doi: 10.1016/j.ijrobp.2018.11.008. Epub 2018 Nov 27. Int J Radiat Oncol Biol Phys. 2019. PMID: 30496882 Free PMC article. Clinical Trial.
Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma.
Ulmer S, Spalek K, Nabavi A, Schultka S, Mehdorn HM, Kesari S, Dörner L. Ulmer S, et al. Neuro Oncol. 2012 Apr;14(4):482-90. doi: 10.1093/neuonc/nos003. Epub 2012 Feb 8. Neuro Oncol. 2012. PMID: 22319220 Free PMC article.
Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas.
Heinzel A, Stock S, Langen KJ, Müller D. Heinzel A, et al. Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1089-96. doi: 10.1007/s00259-012-2093-0. Epub 2012 Mar 15. Eur J Nucl Med Mol Imaging. 2012. PMID: 22419257
Incorporating BCNU wafers into malignant glioma treatment: European case studies.
Balossier A, Dörner L, Emery E, Heese O, Mehdorn HM, Menei P, Singh J. Balossier A, et al. Clin Drug Investig. 2010;30(3):195-204. doi: 10.2165/11532900-000000000-00000. Clin Drug Investig. 2010. PMID: 20155992

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information